Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Flunitrazepam is a benzodiazepine used to manage anxiety disorders and insomnia. Flunitrazepam is a benzodiazepine with pharmacologic actions similar to those of diazepam that can cause anterograde amnesia.
- Mechanism
- Curator reviewed
Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.
- Primary indication
- For short-term treatment of severe insomnias, that are not responsive to other hypnotics.Curator reviewed · 2 structured indications
- Formula / weight
- C16H12FN3O3 · 313.2832 g/mol (avg)
- Code names
- RO 5-4200
Resolves to
PPTYJKAXVCCBDU-UHFFFAOYSA-NSMILESCN1C2=C(C=C(C=C2)[N+]([O-])=O)C(=NCC1=O)C1=CC=CC=C1FWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Flunitrazepam, and which of those have an active Phase 3 trial?